1 0

    FDA Case Reports on Xofigo (Radium Ra 223 Dichloride) – Sixth Academic Request

    FDA Case Reports on Xofigo (Radium Ra 223 Dichloride) – Sixth Academic Request

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: We are requesting case reports on the specified case numbers on toxicities/adverse effects associated with administration of Xofigo (radium Ra 223 dichloride). This request is via the Freedom of Information Act. The reason for the request is for academic purposes. As per our previous communication, we have divided our requests in the form of 12 each. We have paid the fees of our previous requests using the portal we received via email. This is our sixth Xofigo request.
    Tags: Pharma, Adverse Event, 2025
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

    View full details